Rojuzda 25 Mg Injection 1 No's

• Patients with beta thalassemia
• Patients with very low- to intermediate-risk myelodysplastic syndromes (MDS)

• Fatigue
• Bone, joint, or muscle pain
• Headache, Dizziness or vertigo
• Diarrhoea, nausea
• High blood pressure
• Swelling (oedema), particularly in the legs
• Cough, shortness of breath

• Injection-site reactions such as redness or itching Fast heartbeat
• Fainting or light-headedness
• Reduced kidney function
• Low platelet count
• Allergic reactions

• Signs of a blood clot, such as sudden swelling, pain or warmth in a leg, chest pain, sudden shortness of breath, or symptoms of a stroke
• Severe or persistent high blood pressure
• Symptoms of growths of blood-forming tissue ( extramedullary hematopoietic masses )outside the marrow, such as new or worsening back pain, weakness, or numbness (mainly in beta thalassemia)
• Severe allergic reaction, such as swelling of the face or throat, difficulty breathing, or a rash with hives

Other General Warnings

• If you have a history of blood clots (such as deep vein thrombosis, stroke, or pulmonary embolism) , particularly if you have beta thalassemia
• If you have high blood pressure or a history of hypertension
• If you have had your spleen removed, or have an enlarged spleen or liver
• If your haemoglobin rises rapidly or becomes too high, as your doctor may need to adjust or temporarily interrupt treatment
• Tell your doctor if you develop new or worsening back pain, weakness, numbness, or other nerve-related symptoms, especially if you have beta-thalassemia, as these may be signs of extramedullary haematopoietic masses.

• It is given as an injection by a trained healthcare professional.
• Your doctor will check your haemoglobin level and transfusion history before each dose to decide if any adjustment is needed.
• Patients should never attempt to change, delay, skip, or repeat a dose on their own

• Rojuzda powder for injection should be stored refrigerated in its original carton to protect it from light.
• Do not freeze.
• It is handled and prepared by trained healthcare staff and administered shortly after reconstitution.
• Keep out of the reach of children and pets.
• Unused medicine or waste material should be disposed of according to local guidelines for medicinal waste.

• Report any new or worsening back pain, weakness, or numbness, especially if you have beta thalassemia, as this may need prompt evaluation by your doctor.
• Tell your doctor about swelling, pain, or warmth in a leg, or sudden chest pain or breathlessness, as these could be signs of a blood clot.
• Attend all appointments for blood pressure checks and blood tests during treatment.
• Inform your doctor about any signs of an allergic reaction, such as rash, swelling, or difficulty breathing.

Overdose

• There is no specific antidote for Rojuzda powder for injection overdose.
• Overdose is unlikely as the medicine is given by a healthcare professional. If it occurs, supportive treatment and monitoring should be provided by your doctor.

Missed a Dose

Interactions with other medicines

• Tell your doctor about all prescription medicines, over-the-counter medicines, and supplements you are taking.
• No significant drug-drug interaction has been identified between Rojuzda powder for injection
• Your doctor will continue to monitor your blood pressure and other conditions that may affect your treatment.